Systematic Review with Meta-Analysis: Efficacy and Safety of Lusutrombopag for Severe Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures

INTRODUCTION: Lusutrombopag is an oral thrombopoietin receptor agonist (TPO-RA). Clinical trials have shown lusutrombopag’s efficacy in reducing need for preoperative platelet transfusion in patients with chronic liver disease (CLD) and severe thrombocytopenia. This analysis assessed efficacy and sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Orme, Michelle E., Bentley, Roy, Marcella, Stephen, Peck-Radosavljevic, Markus, Perard, Rodolphe, Wedemeyer, Heiner, Yoshiji, Hitoshi, Agarwal, Kosh, Dusheiko, Geoffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402754/
https://www.ncbi.nlm.nih.gov/pubmed/35836089
http://dx.doi.org/10.1007/s12325-022-02235-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402754/
https://www.ncbi.nlm.nih.gov/pubmed/35836089
http://dx.doi.org/10.1007/s12325-022-02235-w

Ejemplares similares